Commercial adoption of the LIBERTY System by sites that participated in the clinical trial serves as a strong validation of the value it brings ...

Microbot Medical Inc. (Nasdaq: MBOT), developer and distributor of the innovative LIBERTY ® Endovascular Robotic System, announced that it will highlight recent commercial achievements leading to the ...

MBOT moves to full U.S. launch of its LIBERTY robotic system after strong hospital adoption, boosting momentum for faster market uptake and sales growth.

Microbot Medical Inc. has announced the addition of two senior executives to enhance its U.S. commercial leadership team in preparation for the upcoming launch of its LIBERTY® Endovascular Robotic ...

Microbot Medical (MBOT) concludes 2024 with the achievement of several key milestones, including the recent FDA 510(k) submission for FDA commercial approval of LIBERTY, which the company believes ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Microbot Medical Inc. (NASDAQ:MBOT) shares are trading higher Monday after the company announced that it has received FDA approval to proceed with its human clinical trial as part of its ...

Shares of Microbot Medical Inc. rocketed 67.3% toward a nine-month high on heavy volume in premarket trading Monday, after the pre-clinical medical device company announced an agreement with Stryker ...

Microbot Medical Inc (NASDAQ:MBOT) shares are trading higher by 22% to $2.58 during Monday’s session after the company announced it sold 4.26 million shares under an ATM agreement and generated $4.82 ...